| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |